Roche Cobas

The Florida Department of Health (DOH) Bureau of Public Health Laboratories (BPHL) is seeking to procure a FDA-approved Roche Cobas 5800 analyzer through a single-source acquisition. The Cobas 5800 is required to support a comprehensive refugee testing pathway at the BPHL Jacksonville laboratory, as it is compatible with multiple HIV and STI molecular assays. The Cobas 5800 allows for HIV-1/HIV-2 Differentiating RNA testing and CT/NG/TV/MG quad testing from a single patient sample, reducing the need for multiple visits and blood draws. The estimated dollar value for this one-year contract is $200,000. The justification for the single-source procurement is that Roche Molecular is the exclusive manufacturer and distributor of the Cobas 5800 instrument, which is the sole FDA-approved analyzer system for use with the required HIV and STI molecular assays at the BPHL Jacksonville lab.

This opportunity is limited to Roche Molecular as the sole-source provider. There are no set-aside designations or restrictions on the types of organizations that can respond. Additionally, there is no information provided about any incumbent vendors or existing infrastructure that would require integration. The total budget for this procurement is $200,000 for a one-year term.